ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase I Study of the Effects of APF530 Exposure, Granisetron and Moxifloxacin

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01416259
Recruitment Status : Completed
First Posted : August 15, 2011
Last Update Posted : August 4, 2015
Sponsor:
Information provided by (Responsible Party):
Heron Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2011
  Actual Study Completion Date : October 2011